Neurocognitive Risk With PCSK9 Inhibitors

被引:3
作者
Khan, Abdur Rahman [1 ]
Riaz, Haris [1 ]
Farid, Talha [1 ]
Bolli, Roberto [1 ]
机构
[1] Univ Louisville, Dept Med, Div Cardiovasc Med, 200 Abraham Flexner Way, Louisville, KY 40202 USA
基金
美国国家卫生研究院;
关键词
CARDIOVASCULAR EVENTS; REDUCING LIPIDS; SAFETY; ALIROCUMAB; EFFICACY;
D O I
10.1016/j.jacc.2017.02.063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2468 / 2469
页数:3
相关论文
共 5 条
[1]   Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors [J].
Khan, Abdur Rahman ;
Bavishi, Chirag ;
Riaz, Haris ;
Farid, Talha A. ;
Khan, Sobia ;
Atlas, Michel ;
Hirsch, Glenn ;
Ikram, Sohail ;
Bolli, Roberto .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (01)
[2]   The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis [J].
Lipinski, Michael J. ;
Benedetto, Umberto ;
Escarcega, Ricardo O. ;
Biondi-Zoccai, Giuseppe ;
Lhermusier, Thibault ;
Baker, Nevin C. ;
Torguson, Rebecca ;
Brewer, H. Bryan, Jr. ;
Waksman, Ron .
EUROPEAN HEART JOURNAL, 2016, 37 (06) :536-U103
[3]   Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab Pooled Data From Randomized Trials [J].
Robinson, Jennifer G. ;
Rosenson, Robert S. ;
Farnier, Michel ;
Chaudhari, Umesh ;
Sasiela, William J. ;
Merlet, Laurence ;
Miller, Kathryn ;
Kastelein, John J. P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (05) :471-482
[4]   Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events [J].
Robinson, Jennifer G. ;
Farnier, Michel ;
Krempf, Michel ;
Bergeron, Jean ;
Luc, Gerald ;
Averna, Maurizio ;
Stroes, Erik S. ;
Langslet, Gisle ;
Raal, Frederick J. ;
El Shahawy, Mahfouz ;
Koren, Michael J. ;
Lepor, Norman E. ;
Lorenzato, Christelle ;
Pordy, Robert ;
Chaudhari, Umesh ;
Kastelein, John J. P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (16) :1489-1499
[5]   Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events [J].
Sabatine, Marc S. ;
Giugliano, Robert P. ;
Wiviott, Stephen D. ;
Raal, Frederick J. ;
Blom, Dirk J. ;
Robinson, Jennifer ;
Ballantyne, Christie M. ;
Somaratne, Ransi ;
Legg, Jason ;
Wasserman, Scott M. ;
Scott, Robert ;
Koren, Michael J. ;
Stein, Evan A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (16) :1500-1509